iCAN Digital Precision Medicine Eastern Finland (iCANEAST)
07.08.2025
iCANEAST focuses on digital precision cancer medicine integrating digital technology, data analysis, and personalized medical care to enhance cancer treatment and research. Molecular profiling of tumors identifying genetic mutations driving cancer progression, and liquid biopsies, providing a non-invasive method to monitor disease and response to treatment, are the key elements. Bioinformatics analyses and AI-driven approaches are leading to insights that can drive the development of precision medicine strategies. We develop processes to produce and analyze molecular alterations of tumors and related clinical data in a secure computing environment. ICANEAST will include altogether samples and data from 350 biobank consented patients.
